Kingsview Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.55M Buy
12,016
+5,033
+72% +$1.49M 0.05% 376
2025
Q4
$1.91M Buy
6,983
+173
+3% +$47K 0.03% 482
2025
Q3
$1.84M Buy
6,810
+3,751
+123% +$1.02M 0.03% 467
2025
Q2
$843K Sell
3,059
-8
-0.3% -$2.18K 0.01% 632
2025
Q1
$814K Sell
3,067
-8,609
-74% -$2.12M 0.02% 597
2024
Q4
$2.71M Buy
11,676
+8,147
+231% +$1.87M 0.05% 319
2024
Q3
$779K Sell
3,529
-38
-1% -$7.86K 0.02% 594
2024
Q2
$701K Buy
3,567
+54
+2% +$11.2K 0.02% 590
2024
Q1
$756K Buy
3,513
+632
+22% +$133K 0.02% 571
2023
Q4
$607K Buy
2,881
+116
+4% +$24.8K 0.02% 596
2023
Q3
$554K Buy
2,765
+39
+1% +$7.75K 0.02% 593
2023
Q2
$505K Sell
2,726
-97
-3% -$17.9K 0.02% 588
2023
Q1
$541K Sell
2,823
-2,365
-46% -$428K 0.02% 552
2022
Q4
$872K Sell
5,188
-4,090
-44% -$711K 0.04% 373
2022
Q3
$1.64M Buy
9,278
+118
+1% +$23.3K 0.08% 250
2022
Q2
$1.88M Buy
9,160
+816
+10% +$173K 0.09% 228
2022
Q1
$1.98M Sell
8,344
-11
-0.1% -$2.58K 0.09% 244
2021
Q4
$1.91M Sell
8,355
-28
-0.3% -$6.16K 0.08% 254
2021
Q3
$1.62M Sell
8,383
-28
-0.3% -$5.67K 0.08% 266
2021
Q2
$1.8M Buy
8,411
+894
+12% +$189K 0.09% 243
2021
Q1
$1.54M Sell
7,517
-332
-4% -$65.4K 0.09% 236
2020
Q4
$1.43M Sell
7,849
-406
-5% -$69K 0.1% 206
2020
Q3
$1.38M Sell
8,255
-233
-3% -$39.2K 0.12% 175
2020
Q2
$1.38M Sell
8,488
-19
-0.2% -$3.41K 0.14% 164
2020
Q1
$1.47M Buy
8,507
+407
+5% +$81K 0.2% 133
2019
Q4
$1.63M Buy
8,100
+119
+1% +$24.4K 0.2% 139
2019
Q3
$1.69M Sell
7,981
-76
-0.9% -$15.9K 0.27% 113
2019
Q2
$1.56M Sell
8,057
-63
-0.8% -$11.6K 0.26% 108
2019
Q1
$1.34M Buy
8,120
+308
+4% +$54.5K 0.2% 135
2018
Q4
$1.47M Buy
7,812
+188
+2% +$34.7K 0.32% 100
2018
Q3
$1.3M Buy
7,624
+87
+1% +$14.6K 0.26% 115
2018
Q2
$1.24M Sell
7,537
-100
-1% -$16.3K 0.3% 107
2018
Q1
$1.24M Buy
7,637
+1
+0% +$159 0.31% 96
2017
Q4
$1.12M Buy
7,636
+117
+2% +$16.7K 0.4% 70
2017
Q3
$1.02M Sell
7,519
-31
-0.4% -$3.92K 0.45% 66
2017
Q2
$946K Sell
7,550
-310
-4% -$37.1K 0.49% 61
2017
Q1
$772K Buy
+7,860
New +$945K 0.46% 72

Other funds holding CME